These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14596072)

  • 21. National Institutes of Health Consensus Development Conference statement Management of Hepatitis C: 2002 June 10-12, 2002.
    HIV Clin Trials; 2003; 4(1):55-75. PubMed ID: 12577198
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of hepatitis C virus infection in patients with chronic generalized pruritus.
    Aydingoz IE; Ozcivan M; Mansur T
    Dermatology; 2005; 211(2):170-1. PubMed ID: 16088171
    [No Abstract]   [Full Text] [Related]  

  • 23. Perinatal hepatitis C infection.
    Hupertz VF; Wyllie R
    Pediatr Infect Dis J; 2003 Apr; 22(4):369-72. PubMed ID: 12690280
    [No Abstract]   [Full Text] [Related]  

  • 24. ["Hepatitis C awareness, searching for it and referral for therapy"].
    Zeuzem S
    MMW Fortschr Med; 2006 Apr; 148(16):8. PubMed ID: 16688939
    [No Abstract]   [Full Text] [Related]  

  • 25. Newly acquired hepatitis C--many hurdles from diagnosis until treatment initiation.
    Wiegand J
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1782-4. PubMed ID: 19120870
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute hepatitis C.
    Marinos G; Post J
    Aust Fam Physician; 2003 Oct; 32(10):804-6. PubMed ID: 14596075
    [No Abstract]   [Full Text] [Related]  

  • 27. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
    Ahmad N; Asgher M; Shafique M; Qureshi JA
    Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection fighters. Hepatitis C and HIV.
    TreatmentUpdate; 2005; 17(1):7. PubMed ID: 17225318
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical management of HIV/hepatitis C virus coinfection.
    Pozza R
    J Am Acad Nurse Pract; 2008 Oct; 20(10):496-505. PubMed ID: 19128345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occult hepatitis C: how convincing are the current data?
    Welker MW; Zeuzem S
    Hepatology; 2009 Feb; 49(2):665-75. PubMed ID: 19105211
    [No Abstract]   [Full Text] [Related]  

  • 31. The face of future hepatitis C antiviral drug development: recent biological and virologic advances and their translation to drug development and clinical practice.
    McHutchison JG; Bartenschlager R; Patel K; Pawlotsky JM
    J Hepatol; 2006 Feb; 44(2):411-21. PubMed ID: 16364491
    [No Abstract]   [Full Text] [Related]  

  • 32. How Greek GPs manage hepatitis C infected patients: experiences gained from a primary health care district in rural Crete.
    Lionis C; Frangoulis E; Skliros S; Alexandrakis E; Kouroumalis E
    Aust Fam Physician; 1999 Mar; 28(3):207. PubMed ID: 10098297
    [No Abstract]   [Full Text] [Related]  

  • 33. Using a surveillance system to identify and treat newly acquired hepatitis C infection.
    Walsh N; Lim M; Hellard M
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1891-4. PubMed ID: 19120877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fifteen years of investigations on hepatitis C virus in Poland].
    Juszczyk J
    Przegl Epidemiol; 2005; 59(2):373-84. PubMed ID: 16190544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current and future applications of viral clearance kinetics in the treatment of hepatitis C].
    Buti M
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():24-9. PubMed ID: 15195531
    [No Abstract]   [Full Text] [Related]  

  • 36. Epidemiology of hepatitis C virus infection in Australia.
    Dore GJ; MacDonald M; Law MG; Kaldor JM
    Aust Fam Physician; 2003 Oct; 32(10):796-8. PubMed ID: 14596073
    [No Abstract]   [Full Text] [Related]  

  • 37. Current challenges in hepatitis C.
    Swan T
    Res Initiat Treat Action; 2004; 10(2):17-20. PubMed ID: 15828096
    [No Abstract]   [Full Text] [Related]  

  • 38. Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation.
    Giostra E; Kullak-Ublick GA; Keller W; Fried R; Vanlemmens C; Kraehenbuhl S; Locher S; Egger HP; Clavien PA; Hadengue A; Mentha G; Morel P; Negro F
    Transpl Int; 2004 May; 17(4):169-76. PubMed ID: 15060764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for HCV infection: understanding the USPSTF recommendation.
    Randhawa GS; Calonge N
    Am Fam Physician; 2005 Aug; 72(4):579-80. PubMed ID: 16127949
    [No Abstract]   [Full Text] [Related]  

  • 40. Maximizing the benefits of antiviral therapy for HCV: the advantages of treating side effects.
    Gish RG
    Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):xxiii-xxiv. PubMed ID: 15081104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.